Memory impairment due to Post acute COVID-19 syndrome (LONG-Covid Syndrome). SARS-associated coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: This group is treated with Donepezil Hydrochloride with the brand name Aricept at a dose of 5 mg (half a tablet for the first 5 nights and then one tablet overnight
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients with the age between 20- 50 years old Memory impairment after recovery from Covid-19 Volunteer to participate in the study
Exclusion criteria
Exclusion criteria: History of previous cognitive problems History of CVA, head trauma or Cerebral hemorrhage History of underlying physical illnesses affecting cognitive function such as cancer, thyroid disorders, physical disorders with features of cognitive impairment such as Alzheimer's or any type of degenerative neurological disorder such as Parkinson's History of underlying mental illnesses such as major depression, anxiety disorders and psychotic disorders Use of drugs that affect cognitive function such as antidepressants, benzodiazepines, and anticonvulsants such as phenobarbital Drug, stimulant and alcohol using
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of Wechsler Memory Scale Test. Timepoint: Measurement of memory indices at the beginning of the study (before intervention), one month later, three months later and six months after the intervention. Method of measurement: The Wechsler Memory Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Sakhabakhsh
Artesh University of Medical Sciences
Outcome results
None listed